HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
USFDA concludes inspection at SMS Pharmaceuticals’ Central Laboratory Analytical Services
Jun-25-2025

United States Food and Drug Administration (USFDA) has concluded inspection at SMS Pharmaceuticals’ Central Laboratory Analytical Services, located at Hyderabad, Telangana. The inspection, conducted from June 23, 2025 to June 25, 2025, concluded with zero Form 483 observations. 

The Company is committed to meeting the highest quality standards and is further committed to full compliance with CGMP & GLP regulations at all its manufacturing & Analytical facilities. The Central Laboratory Analytical Services is company’s independent testing laboratory, and this was the second successful USFDA inspection for the facility.

SMS Pharmaceuticals is a diversified and integrated pharmaceutical company specialising in API and intermediates for global customers.

  RELATED NEWS >>